FDA OKs Lymphoma 'Breakthrough' Drug

Thursday, 14 Nov 2013 08:15 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. health regulators on Wednesday approved a drug to treat a rare and aggressive form of non-Hodgkin lymphoma developed by Johnson & Johnson and Pharmacyclics Inc, marking the second drug that received the FDA's new breakthrough therapy designation to gain approval.

The drug, to be sold under the brand name, Imbruvica, and known chemically as ibrutinib, was approved to treat mantle cell lymphoma in patients who have received prior treatment with at least one other medicine, such as Celgene Corp's Revlimid.
 
Mantle cell lymphoma represents about 6 percent of non-Hodgkin lymphoma cases in the United States and has typically spread to lymph nodes, bone marrow and other organs by the time it is diagnosed, the Food and Drug Administration said.

Obamacare: Massive New Rules Revealed for 2013

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Women Fare Worse Than Men After Heart Attacks: Yale Study

Monday, 21 Jul 2014 16:43 PM

Despite recent advances in preventing heart attacks among U.S.seniors, those gains don't seem to have occurred among mid . . .

Pregnant Moms Who Smoke More Likely to Have Kids with ADHD

Monday, 21 Jul 2014 16:20 PM

Children born to women who smoked during pregnancy appear to have an increased risk of developing attention-deficit/hype . . .

Probiotics Can Ease High Blood Pressure: Study

Monday, 21 Jul 2014 16:13 PM

A new study suggests that potential help in lowering high blood pressure might be as close as your refrigerator.
Th . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved